Despite gender differences in cardiovascular disease, data is limited on the utility of sex-specific high-sensitivity cardiac troponin (hs-cTn) cut-off values. We aimed to determine the clinical impact of sex-specific hs-cTnT cut-off values (>14ng/L vs >16.8ng/L for males, >9ng/L vs >14ng/L for females) in evaluating patients with chest pain in emergency department. Patients >18 years old with chest pain and hs-cTnT were studied. We excluded patients with ST-segment elevation myocardial infarction, lacked serial hs-cTnT, on dialysis or had trauma-related chest pain. Data were collected retrospectively on baseline characteristics, serial hs-cTnT, discharge diagnosis, coronary anatomy, functional tests and clinical outcome(s) during admission and at one-year follow-up. 1049 patients were included. Regardless of cut-off value, 69/589 males (11.7%) had at least one abnormal troponin with >20% change and were judged to have an ischaemic event. In females, using gender specific cut-off, 13 (2.8%) additional subjects had at least one abnormal troponin with >20% change. 6 were judged to have an ischaemic event and cardiac stress testing (CST) was recommended. 1/2 who did not undergo CST had recurrent admissions for congestive heart failure. 1/4 had positive CST. 7/13 were judged to have a non-ischaemic event and had no further cardiac presentations. Our data showed no change in males, but more false positives in females. However, as only one of the additional 13 females who were identified using the new cut-off had a further cardiac presentation, further investigation is warranted to establish whether sex specific cut-offs improve outcomes for females.
Read full abstract